TY - JOUR T1 - MHRA: confusion over drug names JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 26 LP - 26 DO - 10.1136/dtb.2018.3.0592 VL - 56 IS - 3 A2 - , Y1 - 2018/03/01 UR - http://dtb.bmj.com/content/56/3/26.1.abstract N2 - Recent examples of medication errors arising from confusion between drug names (generic or brand) that look or sound similar have been highlighted by the Medicines and Healthcare products Regulatory Agency (MHRA).1 In 2010 and 2013, the MHRA issued safety alerts to remind healthcare professionals of the risks associated with confusion over drug names.2,3 The latest alert provides another reminder to … ER -